Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

Published 2011 View Full Article

Authors

Keywords

Journal

LANCET NEUROLOGY

Volume 10, Issue 7, Pages 618-625

Publisher

Elsevier BV

Online

2011-06-03

DOI

10.1016/s1474-4422(11)70108-9

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

LANCET NEUROLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Discover Peeref hubs

Ask a Question. Answer a Question.